68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

Summary

The goal of this research is to examine the ability of Gallium-68 (68Ga) Prostate-Specific Membrane Antigen-11 (PSMA-11) positron emission tomography/computed tomography (PET/CT) to detect sites of recurrent prostate cancer in patients with biochemical recurrence previously treated with radical prostatectomy (RP) or external beam radiation (EBRT) and to assess treatment response to subsequent salvage therapy.

Timeline

Start

2021-03-19

Primary completion

2023-04-05

Completion

2023-04-05

Drugs

Indications